Qiagen closed higher Friday after the diagnostics company reaffirmed the efficacy of its PCR tests against the new Covid variant which scrambled stock markets on Friday.
The stock closed 3.5% higher at $56.47.
Qiagen (ticker: QGEN) said it assessed its SARS-CoV-2 PCR tests against the new genetic mutations of the variant, known by its scientific…